Sealed for certain

Published: 18-May-2002


Being shown for the first time in the UK by Flowserve are the latest M–Series Mixerpac seals. These can be configured to operate wet, dry or with non-contacting gas barrier technology. The dual pressurised cartridge canister seal is specifically engineered to deal with the lower rotational speed, higher pressure and elevated temperatures generated with modern mixers, dryers and agitators.

Other seals being exhibited include the VRA dry-running seal for top entry mixers, the MSS split seal and the Flowserve GX – 200 seal, which will upgrade any standard bore pump to high performance gas-barrier technology.

Stand G307

  • Companies:
  • Flowserve Corporation
See more

You may also like

Training & Education

Flowserve opens training centre in Italy

Read more
Adds to global network of Learning Resource Centres

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Training & Education

Flowserve opens training centre in Italy

Adds to global network of Learning Resource Centres
Manufacturing

New Flowserve digital positioner features predictive diagnostics

Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
Manufacturing

Flowserve swing check valves help increase reliability in chemical applications

Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability

Flowserve Digital Positioner Introduces ValveSightTM Diagnostics Capabilities to Intrinsically Safe Market

<p>Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, today announced the release of the Flowserve Logix 520MD, the latest addition to the Logix series digital positioner family.&nbsp; This improved smart positioner has the option to add pressure sensors and gives intrinsically safe positioner users the full diagnostic functionality of Flowserve ValveSightTM communication tools.</p>
Research & Development

Compact process thermostat for efficient temperature control in the laboratory

The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
Drug Delivery

Adult vaccination programmes deliver significant socio-economic benefits, study finds

The study shows that adult immunisation programmes return 19x their initial investment, which could ease the pressure on health systems
Cell & Gene Therapy

AviadoBio expands presence at Canary Wharf

The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Subscribe now